ESR1 and breast cancer: While EXO1 overexpression has predominantly been associated with basal-like breast cancers, our analysis of the PAM50 data revealed that EXO1 is also elevated in a subset of ER-positive tumors, suggesting that EXO1’s involvement in HR deficiency might extend beyond the basal-like subtype.